Evaluation of NHANES biomonitoring data for volatile organic chemicals in blood: Application of chemical-specific screening criteria

Journal of Exposure Science and Environmental Epidemiology

Volumn 22, Issue 1, 2012, Pages 24-34

  Kirman, Christopher R ^a   Aylward, Lesa L ^a   Blount, Ben C ^b   Pyatt, David W ^a   Hays, Sean M ^a  

^a LLP   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

biomonitoring; biomonitoring equivalents; risk assessment; VOCs; volatile organic compounds

Indexed keywords

VOLATILE ORGANIC COMPOUND;

ARTICLE; BLOOD; COMPARATIVE STUDY; ENVIRONMENTAL MONITORING; EVALUATION; HUMAN; LIMIT OF DETECTION; METHODOLOGY; NUTRITION; POLLUTANT; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; UNITED STATES;

ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; HUMANS; LIMIT OF DETECTION; NUTRITION SURVEYS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; UNITED STATES; VOLATILE ORGANIC COMPOUNDS;

EID: 84355161673     PISSN: 15590631     EISSN: 1559064X     Source Type: Journal    
DOI: 10.1038/jes.2011.37     Document Type: Article

References (22)

1. Ashley D.L., Bonin M.A., Hamar B., and McGeehin M. Using the blood concentration of 2,5-dimethylfuran as a marker for smoking. Int Arch Occup Environ Health 1996: 68: 183-187. (Pubitemid 26079737)
2. Aylward L.L., Kirman C.R., Blount B.C., and Hays S.M. Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)Fapplication of steady-state PBPK model solutions. Regul Toxicol Pharmacol 2010: 58: 33-44.
3. Aylward L.L., LaKind J.S., and Hays S.M. Biomonitoring equivalents (BE) dossier for trihalomethanes. Regul Toxicol Pharmacol 2008: 51: S68-S77.
4. Blount B.C., Kobelski R.J., McElprang D.O., Ashley D.L., Morrow J.C., Chambers D.M., and Cardinali F.L. Quantification of 31 volatile organic compounds in whole blood using solid-phase microextraction and gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2006: 832: 292-301. (Pubitemid 43339961)
5. Centers for Disease Control and Prevention (CDC). Third National Report on Human Exposure to Environmental Chemicals. Department of Health and Human Services: Atlanta, GA
6. Centers for Disease Control and Prevention (CDC). Fourth National Report on Human Exposure to Environmental Chemicals. Department of Health and Human Services, Center for Disease Control and Prevention: Atlanta, GA, 2009.
7. Chambers D.M., Ocariz J.M., McGuirk M.F., and Blount B.C. Impact of cigarette smoking on volatile organic compound (VOC) blood levels in the U.S. population: NHANES 2003-2004. Environ Int 2011: 37: 1321-1328.
8. Hays S.M., and Aylward L.L. Using biomonitoring equivalents to interpret human biomonitoring data in a public health risk context. J Appl Toxicol 2009: 29: 275-288.
9. Hays S.M., Aylward L.L., LaKind J.S., Bartels M.J., Barton H.A., Boogaard P.J., Brunk C., DiZio S., Dourson M., Goldstein D.A., Lipscomb J., Kilpatrick M.E., Krewski D., Krishnan K., Nordberg M., Okino M., Tan Y.M., Viau C., and Yager J.W. Guidelines for the derivation of biomonitoring equivalents: report from the Biomonitoring Equivalents Expert Workshop. Regul Toxicol Pharmacol 2008: 51: S4-S15.
10. LaKind J.S., Aylward L.L., Brunk C., DiZio S., Dourson M., Goldstein D.A., Kilpatrick M.E., Krewski D., Bartels M.J., Barton H.A., Boogaard P.J., Lipscomb J., Krishnan K., Nordberg M., Okino M., Tan Y.M., Viau C., Yager J.W., and Hays S.M. Guidelines for the communication of biomonitoring equivalents: report from the Biomonitoring Equivalents Expert Workshop. Regul Toxicol Pharmacol 2008: 51: S16-S26.
11. LaKind J.S., Naiman D.Q., Hays S.M., Aylward L.L., and Blount B.C. Public health interpretation of trihalomethane blood levels in the United States: NHANES 1999-2004. J Exp Sci Environ Epidem 2009: 19: 435-441.
12. National Research Council (NRC). Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease. Available at http://www.iom.edu/Reports/ 2010/Evaluation-of-Biomarkers-and-Surrogate-Endpoints-in-Chronic-Disease.aspx
13. SEER. Surveillance Epidemiology and End Results. Online access: http:// seer.cancer.gov/statfacts/html/amyl.html, 2011
14. Sexton K., Adgate J.L., Church T.R., Ashley D.L., Needham L.L., Ramachandran G., Fredrickson A.L., and Ryan A.D. Children's exposure to volatile organic compounds as determined by longitudinal measurements in blood. Environ Health Perspect 2005: 113: 342-349. (Pubitemid 40450669)
15. Sexton K., Adgate J.L., Fredrickson A.L., Ryan A.D., Needham L.L., and Ashley D.L. Using biologic markers in blood to assess exposure to multiple environmental chemicals for inner-city children 3-6 years of age. Environ Health Perspect 2006: 114: 453-459. (Pubitemid 43338273)
16. USEPA. Regional Screening Level (RSL) Summary Table. November 2010. http://www.epa.gov/region9/superfund/prg/. USEPA. Framework for Cumulative Risk Assessment. Risk Assessment Forum. EPA/630/P-02/001F, 2003.
17. USEPA. Risk Assessment Guidance for Superfund. Volume I. Human Health Evaluation Manual (Part A). EPA/540/1-89/002,1 1989. Available at http:// www.epa.gov/oswer/riskassessment/ragsa/pdf/rags-vol1-pta-complete.pdf (accessed on 24 May 2011).
18. USEPA. Supplementary Guidance for Conducting Health Risk Assessment of Chemical Mixtures. US Environmental, EPA/630/R-00/002, 2000
19. USEPA. A review of the reference dose and reference concentration process. US Environmental Protection Agency, EPA/630/P-02/002A, 2002.
20. USEPA. Risk Assessment Guidance for Superfund Volume I: Human Health Evaluation Manual (Part E, Supplemental Guidance for Dermal Risk Assessment). US Environmental Protection Agency, EPA/540/R/99/005, 2004.
21. USEPA. Concepts, Methods and Data Sources for Cumulative Health Risk Assessment of Multiple Chemicals, Exposures and Effects: A Resource Document. US Environmental Protection Agency, EPA/600/R-06/013F, 2007.
22. WHO. Risk assessment of combined exposures to multiple chemicals: a WHO/ IPCS framework. Draft for public and peer review, 2009.